Synthetic Medial Meniscus Implant Demonstrates High Reoperation Rates: Patients Who Retain Implant or Require Implant Exchange SHow Improvement For Post Meniscectomy Knee Pain Is Associated With Clinical Improvement But High Reoperation Rates At 2-Years Post-Operatively.

Thomas Carter, Deryk Jones, Scott Hacker, Wayne Gersoff
{"title":"Synthetic Medial Meniscus Implant Demonstrates High Reoperation Rates: Patients Who Retain Implant or Require Implant Exchange SHow Improvement For Post Meniscectomy Knee Pain Is Associated With Clinical Improvement But High Reoperation Rates At 2-Years Post-Operatively.","authors":"Thomas Carter, Deryk Jones, Scott Hacker, Wayne Gersoff","doi":"10.1016/j.arthro.2024.10.033","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to evaluate the clinical outcomes in the use of a synthetic medial meniscus implant in patients symptomatic after medial meniscectomy and not responsive to other treatment methods. and not responded to non-operative treatment.</p><p><strong>Methods: </strong>This single-arm, multicenter, prospective study enrolled subjects between ages 30-75 with post-meniscectomy pain. Changes from baseline to 24-months were measured in the pain subscale of the knee injury and osteoarthritis outcome score (KOOS) and in KOOS overall (average of all five subscales) in patients that had received a medial meniscus implant. Success was a 20-point improvement at 24-months, reoperation rates, and implant failures were recorded. VAS, IKDC, and WOMET scores were also measured.</p><p><strong>Results: </strong>Of the 115 treated patients 3 (2.6%) were either lost to follow-up or missed the 24-month visit, 48 (43%) patients had at least one subsequent surgery, 12 (10.7%) had the implant permanently removed. Of the remaining 100 patients, the mean KOOS pain improved 28.4 points at 24 months (P <0.001), and mean KOOS overall improved 28.3 points (P < 0.001). Seventy-six percent of subjects had mean scores for KOOS pain above the minimal clinically important difference (MCID) threshold, and 72% of subjects met or exceeded this threshold for KOOS overall. There were 29 patients (25.9%) who underwent implant exchange. The 24-month clinical outcomes were similar between subjects who had an implant exchange and patients who did not have any subsequent implant procedure (P < 0.2).</p><p><strong>Conclusion: </strong>The synthetic medial meniscus demonstrates high reoperation and failure rates. Patients who retained the implant or required implant exchange showed significantly improved pain, function, and quality of life at 24-month follow-up in patients symptomatic following partial medial meniscectomy and failed non-operative management. The high reoperation rate is a concern, and further evaluation is needed to determine any contributing factors.</p>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":" ","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arthro.2024.10.033","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The purpose of this study was to evaluate the clinical outcomes in the use of a synthetic medial meniscus implant in patients symptomatic after medial meniscectomy and not responsive to other treatment methods. and not responded to non-operative treatment.

Methods: This single-arm, multicenter, prospective study enrolled subjects between ages 30-75 with post-meniscectomy pain. Changes from baseline to 24-months were measured in the pain subscale of the knee injury and osteoarthritis outcome score (KOOS) and in KOOS overall (average of all five subscales) in patients that had received a medial meniscus implant. Success was a 20-point improvement at 24-months, reoperation rates, and implant failures were recorded. VAS, IKDC, and WOMET scores were also measured.

Results: Of the 115 treated patients 3 (2.6%) were either lost to follow-up or missed the 24-month visit, 48 (43%) patients had at least one subsequent surgery, 12 (10.7%) had the implant permanently removed. Of the remaining 100 patients, the mean KOOS pain improved 28.4 points at 24 months (P <0.001), and mean KOOS overall improved 28.3 points (P < 0.001). Seventy-six percent of subjects had mean scores for KOOS pain above the minimal clinically important difference (MCID) threshold, and 72% of subjects met or exceeded this threshold for KOOS overall. There were 29 patients (25.9%) who underwent implant exchange. The 24-month clinical outcomes were similar between subjects who had an implant exchange and patients who did not have any subsequent implant procedure (P < 0.2).

Conclusion: The synthetic medial meniscus demonstrates high reoperation and failure rates. Patients who retained the implant or required implant exchange showed significantly improved pain, function, and quality of life at 24-month follow-up in patients symptomatic following partial medial meniscectomy and failed non-operative management. The high reoperation rate is a concern, and further evaluation is needed to determine any contributing factors.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
合成内侧半月板假体的再手术率很高:保留植入物或需要更换植入物的患者显示半月板切除术后膝关节疼痛的改善与临床改善有关,但术后两年的再手术率很高。
目的:本研究旨在评估合成内侧半月板植入物对内侧半月板切除术后出现症状且对其他治疗方法无效的患者的临床疗效:这项单臂、多中心、前瞻性研究招募了年龄在 30-75 岁之间、患有半月板切除术后疼痛的受试者。研究人员测量了接受内侧半月板植入术的患者膝关节损伤和骨关节炎结果评分(KOOS)疼痛分量表和KOOS总评分(所有五个分量表的平均值)从基线到24个月的变化。成功率是指在 24 个月内改善 20 分,记录了再手术率和植入失败率。此外,还对 VAS、IKDC 和 WOMET 评分进行了测量:在接受治疗的 115 名患者中,有 3 名(2.6%)患者失去了随访机会或错过了 24 个月的随访,48 名(43%)患者至少接受了一次后续手术,12 名(10.7%)患者的植入体被永久移除。在剩余的 100 名患者中,24 个月时 KOOS 疼痛平均改善了 28.4 分(P 结论:合成内侧半月板是一种有效的治疗方法:合成内侧半月板的再手术率和失败率都很高。在对部分内侧半月板切除术后出现症状且非手术治疗失败的患者进行 24 个月随访时,保留植入物或需要更换植入物的患者在疼痛、功能和生活质量方面均有明显改善。再次手术率较高是一个令人担忧的问题,需要进一步评估以确定任何诱因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.30
自引率
17.00%
发文量
555
审稿时长
58 days
期刊介绍: Nowhere is minimally invasive surgery explained better than in Arthroscopy, the leading peer-reviewed journal in the field. Every issue enables you to put into perspective the usefulness of the various emerging arthroscopic techniques. The advantages and disadvantages of these methods -- along with their applications in various situations -- are discussed in relation to their efficiency, efficacy and cost benefit. As a special incentive, paid subscribers also receive access to the journal expanded website.
期刊最新文献
Athletes at Highest Risk of ACL Reconstruction Failure are Skeletally Immature Adolescents Treated With Complete Transphyseal All-Soft-Tissue Graft. Increased Tibial Slope and Decreased Medial Proximal Tibial Angle Negatively Affect ACL Graft Maturation: Objective Evidence on When to Add a Lateral Extra-Articular Augmentation Procedure to a Soft Tissue Anterior Cruciate Ligament Reconstruction. Pectoralis minor transfer represents a joint preserving alternative to reverse total shoulder arthroplasty for younger, high-demand patients with irreparable anterosuperior rotator cuff tears. Older Age is Not a Contraindication to Meniscus Repair. Letter Regarding "Adding Dexmedetomidine to Intra-Articular Local Anesthetics Results in Prolonged Analgesia After Knee Arthroscopy: A Systematic Review and Meta-analysis" - Authors' Reply.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1